English
简体中文
Total: £ 56.28
Published Date: 2025-08-11 | Pages: 109 | Tables: 113 | Pharma & Healthcare
The global market for Drug-containing Fat Emulsion was valued at US$ 2300 million in the year 2024 and is projected to reach a revised size of US$ 5085 million by 2031, growing at a CAGR of 12.0% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Drug-containing Fat Emulsion competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, the global production of drug-containing fat emulsion will reach 326.704 million tons, the market size will reach 2300 million US dollars, and the Chinese market size will reach 1303 million US dollars, with an average selling price of US$7.04/gram. Fat emulsion is an oil-in-water (O/W) emulsion made with vegetable oil (mainly ingredient as fatty acid triglycerides) as the oil phase, supplemented by phospholipid emulsifier isotonic agents and water emulsification for injection. According to its function, it can be divided into parenteral nutrition fat emulsion and drug-containing fat emulsion. It was first used for parenteral administration and nutritional supplementation. Among them, drug-containing fat emulsion can solve a series of problems such as drug insolubleness and drug stability. At the same time, drug-containing fat emulsion can solve the drug properties of drug insolubleness through this technology, ensure the stability of the drug during storage, and reduce adverse reactions in patients. Fat milk has the advantages of non-toxicity, high drug loading, able to withstand heat press sterilization and suitable for large-scale industrial production. It has broad application prospects as a drug carrier, and drug-containing fat emulsion has emerged. Drug-containing fat emulsion, insoluble drugs are wrapped in the oil core, and some drugs are distributed in the phospholipid layer, with a particle size of 100 ~ 300 nm. They are widely used in the fields of anesthesia, analgesia, cardiovascular and anti-cancer, such as propofol medium- and long-chain fat emulsion injection, clovidipine butyrate fat emulsion injection, jago gall oil emulsion, etc.
Advantage:
First, drug loading in the oil phase can improve the solubility and stability of the drug; second, loading effect can significantly reduce drug irritation and adverse reactions; third, nutritional fat emulsion injection with refined vegetable oil and lecithin as the main carrier materials has been used for many years and has a low safety risk; fourth, fat emulsion can withstand autoclave and be easy to produce in large quantities in industrialization. Moreover, unlike nutritional fat emulsion, which has a high market concentration, drug-containing fat emulsion has caused various growth in various types of companies in this field due to its application in different therapeutic areas. This growth diversity not only reflects the complexity and potential of the market, but also provides more companies with room for entry and development. Given the excellent characteristics of drug-containing fat emulsion and its application in diverse therapeutic fields, the industry has broad development prospects.
Due to the technical difficulty and cost of drug-containing fat emulsion, the market value of global drug-containing fat emulsion is about twice that of nutritional fat emulsion. Currently, nutritional fat emulsion is almost monopolized by the giant market, while drug-containing fat emulsion has broad development prospects due to different treatment fields.
Market size and drivers:
On the one hand, parenteral nutrition needs continue to be released. In clinical diagnosis and treatment, fat emulsion, as a key component of parenteral nutrition support, is increasing demand for patients who cannot obtain sufficient nutrition through a normal diet, such as intensive care patients, postoperative recovery patients, and people with chronic wasting diseases. On the other hand, the scope of clinical application of fat emulsion has been continuously expanded. In addition to the traditional nutritional supplement field, its application in many fields such as anesthesia and analgesia, cardiovascular disease diagnosis and treatment has gradually deepened, further promoting market growth. At the same time, the optimization of medical insurance payment policies has included some fat emulsion products in the scope of medical insurance reimbursement, which has greatly improved the accessibility of products and stimulated market demand.
In terms of application areas, fat emulsion shows universal applicability. In the field of anesthesia and analgesia, such as the application of etomidate medium/long chain fat emulsion injection, it provides a more effective option for clinical anesthesia. In the diagnosis and treatment of cardiovascular diseases, fat emulsion can be used as a drug carrier to improve the delivery efficiency of drugs and improve the diagnosis and treatment effect.
Technological innovation is the key force in promoting the development of the fat emulsion industry. At present, the industry focuses on breakthroughs in a number of key technologies. Nanopharmacy-loading technology has become a hot topic of research and development. By wrapping the drug in nano-level fat emulsion particles, it can significantly improve the pharmacokinetic characteristics of the drug and improve the stability and bioavailability of the drug. The research and development of intelligent infusion systems is also constantly advancing. This technology can achieve precise control of the fat emulsion infusion process, adjust the infusion speed and dose according to the patient's real-time condition, and improve the safety and effectiveness of diagnosis and treatment. At the same time, the development of low-fat and high-protein formulas and personalized customized products has also made positive progress. Developing customized fat emulsion products in response to the special nutritional needs of different patient groups can better meet the requirements of personalized clinical diagnosis and treatment.
fat emulsion industry has broad prospects. With the intensification of population aging and the increase in the prevalence of chronic diseases, the clinical demand for fat emulsion will continue to grow. Technological innovation will continue to expand the application boundaries of fat emulsion and provide new solutions for the diagnosis and treatment of more diseases. Enterprises should actively respond to policy changes, increase R&D investment, strengthen technological innovation, and enhance their key competitiveness through industry-university-research cooperation. At the same time, pay attention to changes in market demand and develop personalized fat emulsion products to occupy an advantageous position in the fierce market competition. With the joint efforts of all parties, the fat emulsion industry is expected to make greater contributions to the development of the medical and health industry and bring good news to more patients.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug-containing Fat Emulsion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug-containing Fat Emulsion.
The Drug-containing Fat Emulsion market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug-containing Fat Emulsion market comprehensively. Regional market sizes, concerning products by Type, by Application, by Package and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug-containing Fat Emulsion manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Package and by regions.
By Company
Baxter
B. Braun Melsungen AG
Fresenius Kabi AG
Pharmacia(Pfizer)
Teva Pharmaceutical
AstraZeneca
Chongqing Yaoyou Pharmaceutical Co., Ltd.
Sichuan Guorui Pharmaceutical Co.,Ltd.
Xi'an Libang Pharmaceutical Co.,Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Sichuan Kelun Pharmaceutical Co., Ltd.
Yangtze River Pharmaceutical (Group) Co., Ltd.
Anhui Fengyuan Pharmaceutical Co., Ltd.
Yuanda China Holdings Limited
Yichang Humanwell Pharmaceutical Co.,Ltd.
Lee's Pharmaceutical
Yunnan Longhai Natural Phytopharmaceutical Co.,Ltd
SSY Group Limited
Beijing Tide Pharmaceutical Co.,LTD.
Jiabo Pharma
Beijing Tobishi Pharmaceutical Co., Ltd.
Jiangsu Yingke Biopharmaceutical, Co., Ltd.
Segment by Type
Oral Administration Fat Emulsion
Fat Emulsion Intravenous Injection
Eye Administration Fat Emulsion
Nasal Mucosa Administration Fat Emulsion
Lung Administration Fat Emulsion
Segment by Package
10ml:0.1g
20ml:0.1g
20ml:0.2g
50ml:0.5g
50ml:1g
100ml:1g
Segment by Particle Size
Ordinary Fat Emulsion (Particle Size 200~300nm)
Nanofat Emulsion (Particle Size Less than 100nm)
Segment by Disease
Anesthesia and Analgesia
Cardiovascular Disease
Anti-cancer Treatment
Others
Segment by Application
Newborns (Premature Babies) and Babies
Child
Aldult
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug-containing Fat Emulsion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug-containing Fat Emulsion in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Drug-containing Fat Emulsion Market Overview
1.1 Product Definition
1.2 Drug-containing Fat Emulsion by Type
1.2.1 Global Drug-containing Fat Emulsion Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral Administration Fat Emulsion
1.2.3 Fat Emulsion Intravenous Injection
1.2.4 Eye Administration Fat Emulsion
1.2.5 Nasal Mucosa Administration Fat Emulsion
1.2.6 Lung Administration Fat Emulsion
1.3 Drug-containing Fat Emulsion by Package
1.3.1 Global Drug-containing Fat Emulsion Market Value Comparison by Package: 2024 VS 2031
1.3.2 10ml:0.1g
1.3.3 20ml:0.1g
1.3.4 20ml:0.2g
1.3.5 50ml:0.5g
1.3.6 50ml:1g
1.3.7 100ml:1g
1.4 Drug-containing Fat Emulsion by Particle Size
1.4.1 Global Drug-containing Fat Emulsion Market Value Comparison by Particle Size: 2024 VS 2031
1.4.2 Ordinary Fat Emulsion (Particle Size 200~300nm)
1.4.3 Nanofat Emulsion (Particle Size Less than 100nm)
1.5 Drug-containing Fat Emulsion by Disease
1.5.1 Global Drug-containing Fat Emulsion Market Value Comparison by Disease: 2024 VS 2031
1.5.2 Anesthesia and Analgesia
1.5.3 Cardiovascular Disease
1.5.4 Anti-cancer Treatment
1.5.5 Others
1.6 Drug-containing Fat Emulsion by Application
1.6.1 Global Drug-containing Fat Emulsion Market Value by Application (2024 VS 2031)
1.6.2 Newborns (Premature Babies) and Babies
1.6.3 Child
1.6.4 Aldult
1.7 Global Drug-containing Fat Emulsion Market Size Estimates and Forecasts
1.7.1 Global Drug-containing Fat Emulsion Revenue 2020-2031
1.7.2 Global Drug-containing Fat Emulsion Sales 2020-2031
1.7.3 Global Drug-containing Fat Emulsion Market Average Price (2020-2031)
1.8 Assumptions and Limitations
2 Drug-containing Fat Emulsion Market Competition by Manufacturers
2.1 Global Drug-containing Fat Emulsion Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drug-containing Fat Emulsion Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drug-containing Fat Emulsion Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drug-containing Fat Emulsion, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug-containing Fat Emulsion, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug-containing Fat Emulsion, Product Type & Application
2.7 Global Key Manufacturers of Drug-containing Fat Emulsion, Date of Enter into This Industry
2.8 Global Drug-containing Fat Emulsion Market Competitive Situation and Trends
2.8.1 Global Drug-containing Fat Emulsion Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drug-containing Fat Emulsion Players Market Share by Revenue
2.8.3 Global Drug-containing Fat Emulsion Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug-containing Fat Emulsion Market Scenario by Region
3.1 Global Drug-containing Fat Emulsion Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drug-containing Fat Emulsion Sales by Region: 2020-2031
3.2.1 Global Drug-containing Fat Emulsion Sales by Region: 2020-2025
3.2.2 Global Drug-containing Fat Emulsion Sales by Region: 2026-2031
3.3 Global Drug-containing Fat Emulsion Revenue by Region: 2020-2031
3.3.1 Global Drug-containing Fat Emulsion Revenue by Region: 2020-2025
3.3.2 Global Drug-containing Fat Emulsion Revenue by Region: 2026-2031
3.4 North America Drug-containing Fat Emulsion Market Facts & Figures by Country
3.4.1 North America Drug-containing Fat Emulsion Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drug-containing Fat Emulsion Sales by Country (2020-2031)
3.4.3 North America Drug-containing Fat Emulsion Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug-containing Fat Emulsion Market Facts & Figures by Country
3.5.1 Europe Drug-containing Fat Emulsion Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drug-containing Fat Emulsion Sales by Country (2020-2031)
3.5.3 Europe Drug-containing Fat Emulsion Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug-containing Fat Emulsion Market Facts & Figures by Region
3.6.1 Asia Pacific Drug-containing Fat Emulsion Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drug-containing Fat Emulsion Sales by Region (2020-2031)
3.6.3 Asia Pacific Drug-containing Fat Emulsion Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drug-containing Fat Emulsion Market Facts & Figures by Country
3.7.1 Latin America Drug-containing Fat Emulsion Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drug-containing Fat Emulsion Sales by Country (2020-2031)
3.7.3 Latin America Drug-containing Fat Emulsion Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Drug-containing Fat Emulsion Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug-containing Fat Emulsion Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drug-containing Fat Emulsion Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drug-containing Fat Emulsion Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug-containing Fat Emulsion Sales by Type (2020-2031)
4.1.1 Global Drug-containing Fat Emulsion Sales by Type (2020-2025)
4.1.2 Global Drug-containing Fat Emulsion Sales by Type (2026-2031)
4.1.3 Global Drug-containing Fat Emulsion Sales Market Share by Type (2020-2031)
4.2 Global Drug-containing Fat Emulsion Revenue by Type (2020-2031)
4.2.1 Global Drug-containing Fat Emulsion Revenue by Type (2020-2025)
4.2.2 Global Drug-containing Fat Emulsion Revenue by Type (2026-2031)
4.2.3 Global Drug-containing Fat Emulsion Revenue Market Share by Type (2020-2031)
4.3 Global Drug-containing Fat Emulsion Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drug-containing Fat Emulsion Sales by Application (2020-2031)
5.1.1 Global Drug-containing Fat Emulsion Sales by Application (2020-2025)
5.1.2 Global Drug-containing Fat Emulsion Sales by Application (2026-2031)
5.1.3 Global Drug-containing Fat Emulsion Sales Market Share by Application (2020-2031)
5.2 Global Drug-containing Fat Emulsion Revenue by Application (2020-2031)
5.2.1 Global Drug-containing Fat Emulsion Revenue by Application (2020-2025)
5.2.2 Global Drug-containing Fat Emulsion Revenue by Application (2026-2031)
5.2.3 Global Drug-containing Fat Emulsion Revenue Market Share by Application (2020-2031)
5.3 Global Drug-containing Fat Emulsion Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Drug-containing Fat Emulsion Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 B. Braun Melsungen AG
6.2.1 B. Braun Melsungen AG Company Information
6.2.2 B. Braun Melsungen AG Description and Business Overview
6.2.3 B. Braun Melsungen AG Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.2.4 B. Braun Melsungen AG Drug-containing Fat Emulsion Product Portfolio
6.2.5 B. Braun Melsungen AG Recent Developments/Updates
6.3 Fresenius Kabi AG
6.3.1 Fresenius Kabi AG Company Information
6.3.2 Fresenius Kabi AG Description and Business Overview
6.3.3 Fresenius Kabi AG Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fresenius Kabi AG Drug-containing Fat Emulsion Product Portfolio
6.3.5 Fresenius Kabi AG Recent Developments/Updates
6.4 Pharmacia(Pfizer)
6.4.1 Pharmacia(Pfizer) Company Information
6.4.2 Pharmacia(Pfizer) Description and Business Overview
6.4.3 Pharmacia(Pfizer) Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pharmacia(Pfizer) Drug-containing Fat Emulsion Product Portfolio
6.4.5 Pharmacia(Pfizer) Recent Developments/Updates
6.5 Teva Pharmaceutical
6.5.1 Teva Pharmaceutical Company Information
6.5.2 Teva Pharmaceutical Description and Business Overview
6.5.3 Teva Pharmaceutical Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Pharmaceutical Drug-containing Fat Emulsion Product Portfolio
6.5.5 Teva Pharmaceutical Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Company Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AstraZeneca Drug-containing Fat Emulsion Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 Chongqing Yaoyou Pharmaceutical Co., Ltd.
6.7.1 Chongqing Yaoyou Pharmaceutical Co., Ltd. Company Information
6.7.2 Chongqing Yaoyou Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Chongqing Yaoyou Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Chongqing Yaoyou Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Product Portfolio
6.7.5 Chongqing Yaoyou Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Sichuan Guorui Pharmaceutical Co.,Ltd.
6.8.1 Sichuan Guorui Pharmaceutical Co.,Ltd. Company Information
6.8.2 Sichuan Guorui Pharmaceutical Co.,Ltd. Description and Business Overview
6.8.3 Sichuan Guorui Pharmaceutical Co.,Ltd. Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sichuan Guorui Pharmaceutical Co.,Ltd. Drug-containing Fat Emulsion Product Portfolio
6.8.5 Sichuan Guorui Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.9 Xi'an Libang Pharmaceutical Co.,Ltd.
6.9.1 Xi'an Libang Pharmaceutical Co.,Ltd. Company Information
6.9.2 Xi'an Libang Pharmaceutical Co.,Ltd. Description and Business Overview
6.9.3 Xi'an Libang Pharmaceutical Co.,Ltd. Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Xi'an Libang Pharmaceutical Co.,Ltd. Drug-containing Fat Emulsion Product Portfolio
6.9.5 Xi'an Libang Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
6.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Information
6.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Description and Business Overview
6.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Drug-containing Fat Emulsion Product Portfolio
6.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
6.11 Sichuan Kelun Pharmaceutical Co., Ltd.
6.11.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
6.11.2 Sichuan Kelun Pharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Sichuan Kelun Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sichuan Kelun Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Product Portfolio
6.11.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Yangtze River Pharmaceutical (Group) Co., Ltd.
6.12.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
6.12.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.12.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Drug-containing Fat Emulsion Product Portfolio
6.12.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.13 Anhui Fengyuan Pharmaceutical Co., Ltd.
6.13.1 Anhui Fengyuan Pharmaceutical Co., Ltd. Company Information
6.13.2 Anhui Fengyuan Pharmaceutical Co., Ltd. Description and Business Overview
6.13.3 Anhui Fengyuan Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Anhui Fengyuan Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Product Portfolio
6.13.5 Anhui Fengyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Yuanda China Holdings Limited
6.14.1 Yuanda China Holdings Limited Company Information
6.14.2 Yuanda China Holdings Limited Description and Business Overview
6.14.3 Yuanda China Holdings Limited Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Yuanda China Holdings Limited Drug-containing Fat Emulsion Product Portfolio
6.14.5 Yuanda China Holdings Limited Recent Developments/Updates
6.15 Yichang Humanwell Pharmaceutical Co.,Ltd.
6.15.1 Yichang Humanwell Pharmaceutical Co.,Ltd. Company Information
6.15.2 Yichang Humanwell Pharmaceutical Co.,Ltd. Description and Business Overview
6.15.3 Yichang Humanwell Pharmaceutical Co.,Ltd. Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Yichang Humanwell Pharmaceutical Co.,Ltd. Drug-containing Fat Emulsion Product Portfolio
6.15.5 Yichang Humanwell Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.16 Lee's Pharmaceutical
6.16.1 Lee's Pharmaceutical Company Information
6.16.2 Lee's Pharmaceutical Description and Business Overview
6.16.3 Lee's Pharmaceutical Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Lee's Pharmaceutical Drug-containing Fat Emulsion Product Portfolio
6.16.5 Lee's Pharmaceutical Recent Developments/Updates
6.17 Yunnan Longhai Natural Phytopharmaceutical Co.,Ltd
6.17.1 Yunnan Longhai Natural Phytopharmaceutical Co.,Ltd Company Information
6.17.2 Yunnan Longhai Natural Phytopharmaceutical Co.,Ltd Description and Business Overview
6.17.3 Yunnan Longhai Natural Phytopharmaceutical Co.,Ltd Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Yunnan Longhai Natural Phytopharmaceutical Co.,Ltd Drug-containing Fat Emulsion Product Portfolio
6.17.5 Yunnan Longhai Natural Phytopharmaceutical Co.,Ltd Recent Developments/Updates
6.18 SSY Group Limited
6.18.1 SSY Group Limited Company Information
6.18.2 SSY Group Limited Description and Business Overview
6.18.3 SSY Group Limited Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.18.4 SSY Group Limited Drug-containing Fat Emulsion Product Portfolio
6.18.5 SSY Group Limited Recent Developments/Updates
6.19 Beijing Tide Pharmaceutical Co.,LTD.
6.19.1 Beijing Tide Pharmaceutical Co.,LTD. Company Information
6.19.2 Beijing Tide Pharmaceutical Co.,LTD. Description and Business Overview
6.19.3 Beijing Tide Pharmaceutical Co.,LTD. Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Beijing Tide Pharmaceutical Co.,LTD. Drug-containing Fat Emulsion Product Portfolio
6.19.5 Beijing Tide Pharmaceutical Co.,LTD. Recent Developments/Updates
6.20 Jiabo Pharma
6.20.1 Jiabo Pharma Company Information
6.20.2 Jiabo Pharma Description and Business Overview
6.20.3 Jiabo Pharma Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Jiabo Pharma Drug-containing Fat Emulsion Product Portfolio
6.20.5 Jiabo Pharma Recent Developments/Updates
6.21 Beijing Tobishi Pharmaceutical Co., Ltd.
6.21.1 Beijing Tobishi Pharmaceutical Co., Ltd. Company Information
6.21.2 Beijing Tobishi Pharmaceutical Co., Ltd. Description and Business Overview
6.21.3 Beijing Tobishi Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Beijing Tobishi Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Product Portfolio
6.21.5 Beijing Tobishi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.22 Jiangsu Yingke Biopharmaceutical, Co., Ltd.
6.22.1 Jiangsu Yingke Biopharmaceutical, Co., Ltd. Company Information
6.22.2 Jiangsu Yingke Biopharmaceutical, Co., Ltd. Description and Business Overview
6.22.3 Jiangsu Yingke Biopharmaceutical, Co., Ltd. Drug-containing Fat Emulsion Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Jiangsu Yingke Biopharmaceutical, Co., Ltd. Drug-containing Fat Emulsion Product Portfolio
6.22.5 Jiangsu Yingke Biopharmaceutical, Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug-containing Fat Emulsion Industry Chain Analysis
7.2 Drug-containing Fat Emulsion Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug-containing Fat Emulsion Production Mode & Process Analysis
7.4 Drug-containing Fat Emulsion Sales and Marketing
7.4.1 Drug-containing Fat Emulsion Sales Channels
7.4.2 Drug-containing Fat Emulsion Distributors
7.5 Drug-containing Fat Emulsion Customer Analysis
8 Drug-containing Fat Emulsion Market Dynamics
8.1 Drug-containing Fat Emulsion Industry Trends
8.2 Drug-containing Fat Emulsion Market Drivers
8.3 Drug-containing Fat Emulsion Market Challenges
8.4 Drug-containing Fat Emulsion Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Drug-containing Fat Emulsion Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Drug-containing Fat Emulsion Market Value by Package, (US$ Million) & (2024 VS 2031)
Table 3. Global Drug-containing Fat Emulsion Market Value by Particle Size, (US$ Million) & (2024 VS 2031)
Table 4. Global Drug-containing Fat Emulsion Market Value by Disease, (US$ Million) & (2024 VS 2031)
Table 5. Global Drug-containing Fat Emulsion Market Value by Application (2024 VS 2031) & (US$ Million)
Table 6. Global Drug-containing Fat Emulsion Market Competitive Situation by Manufacturers in 2024
Table 7. Global Drug-containing Fat Emulsion Sales (kg) of Key Manufacturers (2020-2025)
Table 8. Global Drug-containing Fat Emulsion Sales Market Share by Manufacturers (2020-2025)
Table 9. Global Drug-containing Fat Emulsion Revenue (US$ Million) by Manufacturers (2020-2025)
Table 10. Global Drug-containing Fat Emulsion Revenue Share by Manufacturers (2020-2025)
Table 11. Global Market Drug-containing Fat Emulsion Average Price (US$/g) of Key Manufacturers (2020-2025)
Table 12. Global Key Players of Drug-containing Fat Emulsion, Industry Ranking, 2022 VS 2023 VS 2024
Table 13. Global Key Manufacturers of Drug-containing Fat Emulsion, Manufacturing Sites & Headquarters
Table 14. Global Key Manufacturers of Drug-containing Fat Emulsion, Product Type & Application
Table 15. Global Key Manufacturers of Drug-containing Fat Emulsion, Date of Enter into This Industry
Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Drug-containing Fat Emulsion by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-containing Fat Emulsion as of 2024)
Table 18. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 19. Global Drug-containing Fat Emulsion Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 20. Global Drug-containing Fat Emulsion Sales by Region (2020-2025) & (kg)
Table 21. Global Drug-containing Fat Emulsion Sales Market Share by Region (2020-2025)
Table 22. Global Drug-containing Fat Emulsion Sales by Region (2026-2031) & (kg)
Table 23. Global Drug-containing Fat Emulsion Sales Market Share by Region (2026-2031)
Table 24. Global Drug-containing Fat Emulsion Revenue by Region (2020-2025) & (US$ Million)
Table 25. Global Drug-containing Fat Emulsion Revenue Market Share by Region (2020-2025)
Table 26. Global Drug-containing Fat Emulsion Revenue by Region (2026-2031) & (US$ Million)
Table 27. Global Drug-containing Fat Emulsion Revenue Market Share by Region (2026-2031)
Table 28. North America Drug-containing Fat Emulsion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. North America Drug-containing Fat Emulsion Sales by Country (2020-2025) & (kg)
Table 30. North America Drug-containing Fat Emulsion Sales by Country (2026-2031) & (kg)
Table 31. North America Drug-containing Fat Emulsion Revenue by Country (2020-2025) & (US$ Million)
Table 32. North America Drug-containing Fat Emulsion Revenue by Country (2026-2031) & (US$ Million)
Table 33. Europe Drug-containing Fat Emulsion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 34. Europe Drug-containing Fat Emulsion Sales by Country (2020-2025) & (kg)
Table 35. Europe Drug-containing Fat Emulsion Sales by Country (2026-2031) & (kg)
Table 36. Europe Drug-containing Fat Emulsion Revenue by Country (2020-2025) & (US$ Million)
Table 37. Europe Drug-containing Fat Emulsion Revenue by Country (2026-2031) & (US$ Million)
Table 38. Asia Pacific Drug-containing Fat Emulsion Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 39. Asia Pacific Drug-containing Fat Emulsion Sales by Region (2020-2025) & (kg)
Table 40. Asia Pacific Drug-containing Fat Emulsion Sales by Region (2026-2031) & (kg)
Table 41. Asia Pacific Drug-containing Fat Emulsion Revenue by Region (2020-2025) & (US$ Million)
Table 42. Asia Pacific Drug-containing Fat Emulsion Revenue by Region (2026-2031) & (US$ Million)
Table 43. Latin America Drug-containing Fat Emulsion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Latin America Drug-containing Fat Emulsion Sales by Country (2020-2025) & (kg)
Table 45. Latin America Drug-containing Fat Emulsion Sales by Country (2026-2031) & (kg)
Table 46. Latin America Drug-containing Fat Emulsion Revenue by Country (2020-2025) & (US$ Million)
Table 47. Latin America Drug-containing Fat Emulsion Revenue by Country (2026-2031) & (US$ Million)
Table 48. Middle East and Africa Drug-containing Fat Emulsion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Middle East and Africa Drug-containing Fat Emulsion Sales by Country (2020-2025) & (kg)
Table 50. Middle East and Africa Drug-containing Fat Emulsion Sales by Country (2026-2031) & (kg)
Table 51. Middle East and Africa Drug-containing Fat Emulsion Revenue by Country (2020-2025) & (US$ Million)
Table 52. Middle East and Africa Drug-containing Fat Emulsion Revenue by Country (2026-2031) & (US$ Million)
Table 53. Global Drug-containing Fat Emulsion Sales (kg) by Type (2020-2025)
Table 54. Global Drug-containing Fat Emulsion Sales (kg) by Type (2026-2031)
Table 55. Global Drug-containing Fat Emulsion Sales Market Share by Type (2020-2025)
Table 56. Global Drug-containing Fat Emulsion Sales Market Share by Type (2026-2031)
Table 57. Global Drug-containing Fat Emulsion Revenue (US$ Million) by Type (2020-2025)
Table 58. Global Drug-containing Fat Emulsion Revenue (US$ Million) by Type (2026-2031)
Table 59. Global Drug-containing Fat Emulsion Revenue Market Share by Type (2020-2025)
Table 60. Global Drug-containing Fat Emulsion Revenue Market Share by Type (2026-2031)
Table 61. Global Drug-containing Fat Emulsion Price (US$/g) by Type (2020-2025)
Table 62. Global Drug-containing Fat Emulsion Price (US$/g) by Type (2026-2031)
Table 63. Global Drug-containing Fat Emulsion Sales (kg) by Application (2020-2025)
Table 64. Global Drug-containing Fat Emulsion Sales (kg) by Application (2026-2031)
Table 65. Global Drug-containing Fat Emulsion Sales Market Share by Application (2020-2025)
Table 66. Global Drug-containing Fat Emulsion Sales Market Share by Application (2026-2031)
Table 67. Global Drug-containing Fat Emulsion Revenue (US$ Million) by Application (2020-2025)
Table 68. Global Drug-containing Fat Emulsion Revenue (US$ Million) by Application (2026-2031)
Table 69. Global Drug-containing Fat Emulsion Revenue Market Share by Application (2020-2025)
Table 70. Global Drug-containing Fat Emulsion Revenue Market Share by Application (2026-2031)
Table 71. Global Drug-containing Fat Emulsion Price (US$/g) by Application (2020-2025)
Table 72. Global Drug-containing Fat Emulsion Price (US$/g) by Application (2026-2031)
Table 73. Baxter Company Information
Table 74. Baxter Description and Business Overview
Table 75. Baxter Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 76. Baxter Drug-containing Fat Emulsion Product
Table 77. Baxter Recent Developments/Updates
Table 78. B. Braun Melsungen AG Company Information
Table 79. B. Braun Melsungen AG Description and Business Overview
Table 80. B. Braun Melsungen AG Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 81. B. Braun Melsungen AG Drug-containing Fat Emulsion Product
Table 82. B. Braun Melsungen AG Recent Developments/Updates
Table 83. Fresenius Kabi AG Company Information
Table 84. Fresenius Kabi AG Description and Business Overview
Table 85. Fresenius Kabi AG Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 86. Fresenius Kabi AG Drug-containing Fat Emulsion Product
Table 87. Fresenius Kabi AG Recent Developments/Updates
Table 88. Pharmacia(Pfizer) Company Information
Table 89. Pharmacia(Pfizer) Description and Business Overview
Table 90. Pharmacia(Pfizer) Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 91. Pharmacia(Pfizer) Drug-containing Fat Emulsion Product
Table 92. Pharmacia(Pfizer) Recent Developments/Updates
Table 93. Teva Pharmaceutical Company Information
Table 94. Teva Pharmaceutical Description and Business Overview
Table 95. Teva Pharmaceutical Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 96. Teva Pharmaceutical Drug-containing Fat Emulsion Product
Table 97. Teva Pharmaceutical Recent Developments/Updates
Table 98. AstraZeneca Company Information
Table 99. AstraZeneca Description and Business Overview
Table 100. AstraZeneca Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 101. AstraZeneca Drug-containing Fat Emulsion Product
Table 102. AstraZeneca Recent Developments/Updates
Table 103. Chongqing Yaoyou Pharmaceutical Co., Ltd. Company Information
Table 104. Chongqing Yaoyou Pharmaceutical Co., Ltd. Description and Business Overview
Table 105. Chongqing Yaoyou Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 106. Chongqing Yaoyou Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Product
Table 107. Chongqing Yaoyou Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 108. Sichuan Guorui Pharmaceutical Co.,Ltd. Company Information
Table 109. Sichuan Guorui Pharmaceutical Co.,Ltd. Description and Business Overview
Table 110. Sichuan Guorui Pharmaceutical Co.,Ltd. Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 111. Sichuan Guorui Pharmaceutical Co.,Ltd. Drug-containing Fat Emulsion Product
Table 112. Sichuan Guorui Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 113. Xi'an Libang Pharmaceutical Co.,Ltd. Company Information
Table 114. Xi'an Libang Pharmaceutical Co.,Ltd. Description and Business Overview
Table 115. Xi'an Libang Pharmaceutical Co.,Ltd. Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 116. Xi'an Libang Pharmaceutical Co.,Ltd. Drug-containing Fat Emulsion Product
Table 117. Xi'an Libang Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 118. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Information
Table 119. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Description and Business Overview
Table 120. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 121. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Drug-containing Fat Emulsion Product
Table 122. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 123. Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
Table 124. Sichuan Kelun Pharmaceutical Co., Ltd. Description and Business Overview
Table 125. Sichuan Kelun Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 126. Sichuan Kelun Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Product
Table 127. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 128. Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
Table 129. Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 130. Yangtze River Pharmaceutical (Group) Co., Ltd. Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 131. Yangtze River Pharmaceutical (Group) Co., Ltd. Drug-containing Fat Emulsion Product
Table 132. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 133. Anhui Fengyuan Pharmaceutical Co., Ltd. Company Information
Table 134. Anhui Fengyuan Pharmaceutical Co., Ltd. Description and Business Overview
Table 135. Anhui Fengyuan Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 136. Anhui Fengyuan Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Product
Table 137. Anhui Fengyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 138. Yuanda China Holdings Limited Company Information
Table 139. Yuanda China Holdings Limited Description and Business Overview
Table 140. Yuanda China Holdings Limited Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 141. Yuanda China Holdings Limited Drug-containing Fat Emulsion Product
Table 142. Yuanda China Holdings Limited Recent Developments/Updates
Table 143. Yichang Humanwell Pharmaceutical Co.,Ltd. Company Information
Table 144. Yichang Humanwell Pharmaceutical Co.,Ltd. Description and Business Overview
Table 145. Yichang Humanwell Pharmaceutical Co.,Ltd. Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 146. Yichang Humanwell Pharmaceutical Co.,Ltd. Drug-containing Fat Emulsion Product
Table 147. Yichang Humanwell Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 148. Lee's Pharmaceutical Company Information
Table 149. Lee's Pharmaceutical Description and Business Overview
Table 150. Lee's Pharmaceutical Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 151. Lee's Pharmaceutical Drug-containing Fat Emulsion Product
Table 152. Lee's Pharmaceutical Recent Developments/Updates
Table 153. Yunnan Longhai Natural Phytopharmaceutical Co.,Ltd Company Information
Table 154. Yunnan Longhai Natural Phytopharmaceutical Co.,Ltd Description and Business Overview
Table 155. Yunnan Longhai Natural Phytopharmaceutical Co.,Ltd Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 156. Yunnan Longhai Natural Phytopharmaceutical Co.,Ltd Drug-containing Fat Emulsion Product
Table 157. Yunnan Longhai Natural Phytopharmaceutical Co.,Ltd Recent Developments/Updates
Table 158. SSY Group Limited Company Information
Table 159. SSY Group Limited Description and Business Overview
Table 160. SSY Group Limited Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 161. SSY Group Limited Drug-containing Fat Emulsion Product
Table 162. SSY Group Limited Recent Developments/Updates
Table 163. Beijing Tide Pharmaceutical Co.,LTD. Company Information
Table 164. Beijing Tide Pharmaceutical Co.,LTD. Description and Business Overview
Table 165. Beijing Tide Pharmaceutical Co.,LTD. Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 166. Beijing Tide Pharmaceutical Co.,LTD. Drug-containing Fat Emulsion Product
Table 167. Beijing Tide Pharmaceutical Co.,LTD. Recent Developments/Updates
Table 168. Jiabo Pharma Company Information
Table 169. Jiabo Pharma Description and Business Overview
Table 170. Jiabo Pharma Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 171. Jiabo Pharma Drug-containing Fat Emulsion Product
Table 172. Jiabo Pharma Recent Developments/Updates
Table 173. Beijing Tobishi Pharmaceutical Co., Ltd. Company Information
Table 174. Beijing Tobishi Pharmaceutical Co., Ltd. Description and Business Overview
Table 175. Beijing Tobishi Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 176. Beijing Tobishi Pharmaceutical Co., Ltd. Drug-containing Fat Emulsion Product
Table 177. Beijing Tobishi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 178. Jiangsu Yingke Biopharmaceutical, Co., Ltd. Company Information
Table 179. Jiangsu Yingke Biopharmaceutical, Co., Ltd. Description and Business Overview
Table 180. Jiangsu Yingke Biopharmaceutical, Co., Ltd. Drug-containing Fat Emulsion Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 181. Jiangsu Yingke Biopharmaceutical, Co., Ltd. Drug-containing Fat Emulsion Product
Table 182. Jiangsu Yingke Biopharmaceutical, Co., Ltd. Recent Developments/Updates
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Drug-containing Fat Emulsion Distributors List
Table 186. Drug-containing Fat Emulsion Customers List
Table 187. Drug-containing Fat Emulsion Market Trends
Table 188. Drug-containing Fat Emulsion Market Drivers
Table 189. Drug-containing Fat Emulsion Market Challenges
Table 190. Drug-containing Fat Emulsion Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
Table 194. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drug-containing Fat Emulsion
Figure 2. Global Drug-containing Fat Emulsion Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug-containing Fat Emulsion Market Share by Type: 2024 & 2031
Figure 4. Oral Administration Fat Emulsion Product Picture
Figure 5. Fat Emulsion Intravenous Injection Product Picture
Figure 6. Eye Administration Fat Emulsion Product Picture
Figure 7. Nasal Mucosa Administration Fat Emulsion Product Picture
Figure 8. Lung Administration Fat Emulsion Product Picture
Figure 9. Global Drug-containing Fat Emulsion Market Value by Package, (US$ Million) & (2020-2031)
Figure 10. Global Drug-containing Fat Emulsion Market Share by Package: 2024 VS 2031
Figure 11. 10ml:0.1g Product Picture
Figure 12. 20ml:0.1g Product Picture
Figure 13. 20ml:0.2g Product Picture
Figure 14. 50ml:0.5g Product Picture
Figure 15. 50ml:1g Product Picture
Figure 16. 100ml:1g Product Picture
Figure 17. Global Drug-containing Fat Emulsion Market Value by Particle Size, (US$ Million) & (2020-2031)
Figure 18. Global Drug-containing Fat Emulsion Market Share by Particle Size: 2024 VS 2031
Figure 19. Ordinary Fat Emulsion (Particle Size 200~300nm) Product Picture
Figure 20. Nanofat Emulsion (Particle Size Less than 100nm) Product Picture
Figure 21. Global Drug-containing Fat Emulsion Market Value by Disease, (US$ Million) & (2020-2031)
Figure 22. Global Drug-containing Fat Emulsion Market Share by Disease: 2024 VS 2031
Figure 23. Anesthesia and Analgesia Product Picture
Figure 24. Cardiovascular Disease Product Picture
Figure 25. Anti-cancer Treatment Product Picture
Figure 26. Others Product Picture
Figure 27. Global Drug-containing Fat Emulsion Market Value by Application (2020-2031) & (US$ Million)
Figure 28. Global Drug-containing Fat Emulsion Market Share by Application: 2024 & 2031
Figure 29. Newborns (Premature Babies) and Babies
Figure 30. Child
Figure 31. Aldult
Figure 32. Global Drug-containing Fat Emulsion Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 33. Global Drug-containing Fat Emulsion Market Size (2020-2031) & (US$ Million)
Figure 34. Global Drug-containing Fat Emulsion Sales (2020-2031) & (kg)
Figure 35. Global Drug-containing Fat Emulsion Average Price (US$/g) & (2020-2031)
Figure 36. Drug-containing Fat Emulsion Report Years Considered
Figure 37. Drug-containing Fat Emulsion Sales Share by Manufacturers in 2024
Figure 38. Global Drug-containing Fat Emulsion Revenue Share by Manufacturers in 2024
Figure 39. Global 5 and 10 Largest Drug-containing Fat Emulsion Players: Market Share by Revenue in Drug-containing Fat Emulsion in 2024
Figure 40. Drug-containing Fat Emulsion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 41. Global Drug-containing Fat Emulsion Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 42. North America Drug-containing Fat Emulsion Sales Market Share by Country (2020-2031)
Figure 43. North America Drug-containing Fat Emulsion Revenue Market Share by Country (2020-2031)
Figure 44. United States Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Canada Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Europe Drug-containing Fat Emulsion Sales Market Share by Country (2020-2031)
Figure 47. Europe Drug-containing Fat Emulsion Revenue Market Share by Country (2020-2031)
Figure 48. Germany Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. France Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. U.K. Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Italy Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Russia Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Asia Pacific Drug-containing Fat Emulsion Sales Market Share by Region (2020-2031)
Figure 54. Asia Pacific Drug-containing Fat Emulsion Revenue Market Share by Region (2020-2031)
Figure 55. China Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Japan Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. South Korea Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. India Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Australia Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. China Taiwan Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. Southeast Asia Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 62. Latin America Drug-containing Fat Emulsion Sales Market Share by Country (2020-2031)
Figure 63. Latin America Drug-containing Fat Emulsion Revenue Market Share by Country (2020-2031)
Figure 64. Mexico Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 65. Brazil Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 66. Argentina Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 67. Colombia Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 68. Middle East and Africa Drug-containing Fat Emulsion Sales Market Share by Country (2020-2031)
Figure 69. Middle East and Africa Drug-containing Fat Emulsion Revenue Market Share by Country (2020-2031)
Figure 70. Turkey Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 71. Saudi Arabia Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 72. UAE Drug-containing Fat Emulsion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 73. Global Sales Market Share of Drug-containing Fat Emulsion by Type (2020-2031)
Figure 74. Global Revenue Market Share of Drug-containing Fat Emulsion by Type (2020-2031)
Figure 75. Global Drug-containing Fat Emulsion Price (US$/g) by Type (2020-2031)
Figure 76. Global Sales Market Share of Drug-containing Fat Emulsion by Application (2020-2031)
Figure 77. Global Revenue Market Share of Drug-containing Fat Emulsion by Application (2020-2031)
Figure 78. Global Drug-containing Fat Emulsion Price (US$/g) by Application (2020-2031)
Figure 79. Drug-containing Fat Emulsion Value Chain
Figure 80. Channels of Distribution (Direct Vs Distribution)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
